Investor Overview

Our Investor Information

Company Overview

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity.

Copyright West LLC. Minimum 15 minutes delayed.

Press Releases
March 30, 2020
Rhythm Pharmaceuticals Provides Updates on Leadership Transition and Business Operations
March 30, 2020
Rhythm Pharmaceuticals Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Setmelanotide in POMC and LEPR Deficiency Obesities
Upcoming Events
More events are coming soon.
Investor FAQs
More FAQs are coming soon.


Delaware, November 2008


222 Berkeley Street, 12th Floor
Boston, MA 02116
Phone: 857-264-4280

CUSIP number


Transfer Agent

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120